Income statement
For the years ended 31 December
Download |
USD millions |
Note |
2015 |
2016 |
||||||||
|
|||||||||||
Revenues |
|
|
|
||||||||
Gross premiums written |
32 249 |
35 622 |
|||||||||
Net premiums written |
30 442 |
33 570 |
|||||||||
Change in unearned premiums |
|
–691 |
–879 |
||||||||
Premiums earned |
29 751 |
32 691 |
|||||||||
Fee income from policyholders |
463 |
540 |
|||||||||
Net investment income – non-participating business1 |
3 436 |
3 661 |
|||||||||
Net realised investment gains/losses – non-participating business2 |
1 206 |
1 484 |
|||||||||
Net investment result – unit-linked and with-profit business |
814 |
5 382 |
|||||||||
Other revenues |
|
44 |
28 |
||||||||
Total revenues |
|
35 714 |
43 786 |
||||||||
|
|
|
|
||||||||
Expenses |
|
|
|
||||||||
Claims and claim adjustment expenses |
–9 848 |
–12 564 |
|||||||||
Life and health benefits |
–9 080 |
–10 859 |
|||||||||
Return credited to policyholders |
|
–1 166 |
–5 099 |
||||||||
Acquisition costs |
–6 419 |
–6 928 |
|||||||||
Operating expenses3 |
|
–3 248 |
–3 358 |
||||||||
Total expenses before interest expenses |
|
–29 761 |
–38 808 |
||||||||
|
|
|
|
||||||||
Income before interest and income tax expense |
|
5 953 |
4 978 |
||||||||
Interest expenses3 |
|
–634 |
–606 |
||||||||
Income before income tax expense |
|
5 319 |
4 372 |
||||||||
Income tax expense |
–651 |
–749 |
|||||||||
Net income before attribution of non-controlling interests |
|
4 668 |
3 623 |
||||||||
|
|
|
|
||||||||
Income/loss attributable to non-controlling interests |
|
–3 |
3 |
||||||||
Net income after attribution of non-controlling interests |
|
4 665 |
3 626 |
||||||||
|
|
|
|
||||||||
Interest on contingent capital instruments |
|
–68 |
–68 |
||||||||
Net income attributable to common shareholders |
|
4 597 |
3 558 |
||||||||
|
|
|
|
||||||||
Earnings per share in USD |
|
|
|
||||||||
Basic |
13.44 |
10.72 |
|||||||||
Diluted |
12.28 |
9.82 |
|||||||||
Earnings per share in CHF4 |
|
|
|
||||||||
Basic |
12.93 |
10.55 |
|||||||||
Diluted |
11.81 |
9.66 |
The accompanying notes are an integral part of the Group financial statements.